Literature DB >> 22507934

Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact.

Stephen D Lawn, Andrew D Kerkhoff, Robin Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22507934     DOI： 10.5588/ijtld.12.0131

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  26 in total

1.  Serological diagnostic assays for HIV-associated tuberculosis in sub-Saharan Africa?

Authors:  Stephen D Lawn
Journal:  Clin Vaccine Immunol       Date:  2014-04-16

2.  Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.

Authors:  Gabriel M Cohen; Paul K Drain; Farzad Noubary; Christie Cloete; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

3.  The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.

Authors:  C F Hanrahan; K Clouse; J Bassett; L Mutunga; K Selibas; W Stevens; L Scott; I Sanne; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2015-07       Impact factor: 2.373

4.  Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Authors:  Anil Pooran; Grant Theron; Lynn Zijenah; Duncan Chanda; Petra Clowes; Lawrence Mwenge; Farirai Mutenherwa; Paul Lecesse; John Metcalfe; Hojoon Sohn; Michael Hoelscher; Alex Pym; Jonny Peter; David Dowdy; Keertan Dheda
Journal:  Lancet Glob Health       Date:  2019-06       Impact factor: 26.763

Review 5.  Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Graeme Meintjes; Haileyesus Getahun; Diane V Havlir; Robin Wood
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

Review 6.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

Review 7.  Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.

Authors:  Stephen D Lawn
Journal:  BMC Infect Dis       Date:  2012-04-26       Impact factor: 3.090

Review 8.  HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.

Authors:  Anthony D Harries; Stephen D Lawn; Haileyesus Getahun; Rony Zachariah; Diane V Havlir
Journal:  J Int AIDS Soc       Date:  2012       Impact factor: 5.396

9.  The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Authors:  Colleen F Hanrahan; Susan E Dorman; Linda Erasmus; Hendrik Koornhof; Gerrit Coetzee; Jonathan E Golub
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Control of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural Malawi.

Authors:  Sebastian M Mboma; Rein M G J Houben; Judith R Glynn; Lifted Sichali; Francis Drobniewski; James Mpunga; Paul E M Fine; Neil French; Amelia C Crampin
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.